A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
From persistent fevers to unexplained weight loss, discover the subtle HIV symptoms doctors say you shouldn't ignore, ...
Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...
It was nearly 30 years ago when Rosember Lopez received a life-altering diagnosis: He was HIV positive. With scant government resources for HIV support at the time in Mexico, Lopez joined advocacy ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
An HIV drug was named “2024 Breakthrough of the Year” by Science Magazine. Biochemistry research from the University of Utah ...
The Associated Press on MSN6d
This is what happens to the body when HIV drugs are stopped for millions of peopleA generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing, from diseases or ...
Analysis Reveals an Additional Mechanism Behind Statin Therapy's Heart-Related Benefits in People With HIV Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps ...
This is why UNAIDS is launching the development of the new Global AIDS Strategy 2026-2031, an ambitious, inclusive, and action-driven plan that will guide the global HIV response for the next five ...
Majola is one of millions of patients in South Africa affected by U.S. President Donald Trump’s global foreign aid freeze, raising worries about HIV patients defaulting on treatment, infection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback